Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

BUY
$11.0 - $21.45 $370,656 - $722,779
33,696 New
33,696 $397,000
Q2 2019

Jul 19, 2019

SELL
$39.92 - $53.86 $341,795 - $461,149
-8,562 Closed
0 $0
Q4 2018

Feb 08, 2019

SELL
$55.63 - $73.24 $29,261 - $38,524
-526 Reduced 5.79%
8,562 $508,000
Q3 2018

Oct 31, 2018

SELL
$52.05 - $66.51 $473,030 - $604,442
-9,088 Reduced 50.0%
9,088 $599,000
Q3 2018

Oct 25, 2018

BUY
$52.05 - $66.51 $473,030 - $604,442
9,088 Added 100.0%
18,176 $1.06 Million
Q2 2018

Aug 03, 2018

BUY
$48.33 - $55.64 $368,467 - $424,199
7,624 Added 520.77%
9,088 $459,000
Q1 2018

May 07, 2018

BUY
$44.44 - $54.39 $65,060 - $79,626
1,464 New
1,464 $77,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $427M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.